5 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
Treatment • Invasive pulmonary ... aspergillosis (IPA) • CNS ... eye Infectious Diseases ... Aspergillosis #Treatment #management ... #pharmacology #
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Ejection Fraction (HFrEF ... coronary artery disease ... endomyocardial biopsy Pharmacology ... heartfailure #diagnosis #management ... #cardiology #pharmacology
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Therapy (GDMT) in HFrEF ... Class I pillars of HFrEF ... span of kidney disease ... #management #pharmacology ... #cardiology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
• 8%-27% for CNS ... : • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... Infection (Diffuse Pulmonary ... Extrathoracic Disseminated Disease ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology